Early outcomes of exon 11 mutants in GIST treated with standard dose Imatinib

BACKGROUND: The exon 11 KIT mutant gastrointestinal stromal tumors (GIST) is a heterogeneous cohort with variable biological behavior based on different mutational subtypes. METHODS: Patients with histologically proven GIST with KIT exon 11 mutations were selected from a prospectively maintained dat...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Ann Transl Med
Hlavní autoři: Ramaswamy, Anant, Bal, Munita, Swami, Rohit, Shetty, Omshree, Bose, Subhadeep, Pai, Trupti, Gurav, Mamta, Gupta, Sudeep, Ostwal, Vikas
Médium: Artigo
Jazyk:Inglês
Vydáno: AME Publishing Company 2017
Témata:
Original Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5395474/
https://ncbi.nlm.nih.gov/pubmed/28462214
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm.2017.03.31
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky